Jim Simons acquired 32.1k Enveric Biosciences shares worth $46.8k. That's 0.00% of their equity portfolio (2811th largest holding). The first Enveric Biosciences trade was made in Q3 2021. Since then Jim Simons bought shares four more times and sold shares on three occasions. The investor's estimated purchase price is $76.1k, resulting in a loss of 39%.